Abiopharma

News list

Custer Kenneth L. 🟢 acquired 613 shares (1 derivative) of ELI LILLY & Co (LLY) Transaction Date: Aug 27, 2025 | Filing ID: 000236

Full text

News bot Aug. 28, 2025, 8:16 p.m.
🔍 Custer Kenneth L. (Executive)

Company: ELI LILLY & Co (LLY)

Report Date: 2025-08-27
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 613
- Total shares held: 9,347
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | shares_owned_after: 9,346.90
- Acquired 613 shares of Phantom Stock (Derivative)
  Date: 2025-08-27 | Code: I | equity_swap_involved: 0 | shares_owned_after: 2,173.46 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3
Footnotes:
- F1: Each share of phantom stock represents the right to receive the cash value of one share of Eli Lilly and Company common stock.
- F2: Reflects reallocation of funds within the reporting person's deferred compensation account.
- F3: Shares of phantom stock are payable in cash following termination of the reporting person's employment with Eli Lilly and Company.